Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.8M | 8.8M | 9.2M | 8.7M |
Cost of revenue | 4.4M | 5.8M | 5.5M | 5.5M |
Gross profit | 7.4M | 3.1M | 3.7M | 3.2M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3M | 1.4M | 1.2M | 970.7K |
Other operating expenses | — | — | — | — |
Operating income | 6.1M | 1.7M | 2.5M | 2.2M |
Non operating interest income | ||||
Income | 286.2K | 282.3K | 292.0K | 270.9K |
Expense | 16.1K | 18.5K | 17.1K | 19.2K |
Other income expense | — | — | — | — |
Pretax income | 5.8M | 1.8M | 2.4M | 2.2M |
Tax provision | 1.5M | 330.8K | 649.5K | 515.6K |
Net income | 4.4M | 1.4M | 1.8M | 1.6M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 325M | 325M | 325M | 325M |
Diluted average shares | 325.1M | 325.1M | 325M | 325M |
EBITDA | 6.3M | 2.1M | 2.7M | 2.4M |
Net income from continuing op. | 5.8M | 1.8M | 2.4M | 2.2M |
Minority interests | -148.7K | -326.0K | -429.9K | -181.9K |
Preferred stock dividends | 0 | 0 | 0 | 0 |